Projects funded by the ACRF
We provide capital grants for one or more of the establishment of capital works and facilities (including scientific equipment and other technologies), and national enterprises in support of all aspects of cancer research, including but not limited to cell and molecular biology, epidemiology, prevention and drug development.
The ACRF is a ‘seed’ funding body and is therefore interested in applications for larger scale research projects whose value is over and above the amount sought directly from ACRF. We expect applicants to leverage ACRF grants to secure any ‘gap’ funding and also to feature multi-disciplinary teams, collaborations and evidence of the translational impacts at a clinical level (with patients).
Assessment of applications
All applications are considered and assessed by the ACRF’s Medical Research Advisory Committee (MRAC), a group of highly distinguished research scientists who are appointed by the ACRF’s Board of Trustees. The procedures of the MRAC are similar to those employed by the National Health & Medical Research Council and include the assessment of applications by referees and independent expert assessors, as well as site visits and interviews of selected short-listed applicants. The MRAC’s recommendations for funding are then reviewed and finalised by the Foundation’s Board of Trustees.
For researchers and scientists
First stage applications for the 2013 Grant Round will be accepted from April 3, 2013.
The 2013 Grant Round closes Friday May 10, 2013.
Please refer to the below 2013 documents for grant guidelines.
If you have any questions regarding ACRF grants process, please contact Cheryl Riddington on 1300 884 988 or firstname.lastname@example.org.